Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Medical-device maker said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been ...

The man who acquired Sound United and founded US Health Company Masimo has been sacked by his own board, and to top that that ...

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

Beyond analysts' top -and-bottom-line estimates for Masimo (MASI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

Smartwatches gather vast amounts of data about our physiology. Now their technology is being harnessed like never before.

Buying $1000 In MASI: If an investor had bought $1000 of MASI stock 10 years ago, it would be worth $5,655.84 today based on a price of $144.22 for MASI at the time of writing.

Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

A US Court hearing the case of Apple Vs Masimo appear to have given Apple a two finger salute by awarding them US$250, the ...